zelicapavir — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Partici
Phase 2 · RSV Infection, RSV |
ENTA ENANTA PHARMACEUTICALS INC | zelicapavir |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|